Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Halank

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Lung|September 14, 2015
MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PHMartin Kolditz, Hans-Jürgen Seyfarth, Heinrike Wilkens, et al.
Respiratory Medicine|June 15, 2017
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension studyMichael Halank, Marius M Hoeper, Hossein-Ardeschir Ghofrani, et al.
Lung|March 11, 2014
Economic evaluation of exercise training in patients with pulmonary hypertensionNicola Ehlken, Cora Verduyn, Henning Tiede, et al.
Plos One|August 1, 2012
Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertensionChristian Nagel, Felix Prange, Stefan Guth, et al.
International Journal of Cardiology|September 30, 2018
Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018Hanno H Leuchte, Henrik Ten Freyhaus, Henning Gall, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Chronic thromboembolic pulmonary hypertension]Stefan Guth, Heinrike Wilkens, Michael Halank, et al.
Respiration; International Review of Thoracic Diseases|February 12, 2011
Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertensionEkkehard Grünig, Nicola Ehlken, Ardeschir Ghofrani, et al.
Respiration; International Review of Thoracic Diseases|November 21, 2021
Value of Cardiopulmonary Exercise Testing in the Prognosis Assessment of Chronic Obstructive Pulmonary Disease Patients: A Retrospective, Multicentre Cohort StudyRalf Ewert, Anne Obst, Andreas Mühle, et al.
BMC Pulmonary Medicine|December 3, 2011
Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapyLars Knudsen, Alexander Schurawlew, Nils Nickel, et al.
Respiratory Research|October 11, 2013
Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionDominik Harzheim, Hans Klose, Fabiola Peña Pinado, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Lung|September 14, 2015
MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PHMartin Kolditz, Hans-Jürgen Seyfarth, Heinrike Wilkens, et al.
Respiratory Medicine|June 15, 2017
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension studyMichael Halank, Marius M Hoeper, Hossein-Ardeschir Ghofrani, et al.
Lung|March 11, 2014
Economic evaluation of exercise training in patients with pulmonary hypertensionNicola Ehlken, Cora Verduyn, Henning Tiede, et al.
Plos One|August 1, 2012
Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertensionChristian Nagel, Felix Prange, Stefan Guth, et al.
International Journal of Cardiology|September 30, 2018
Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018Hanno H Leuchte, Henrik Ten Freyhaus, Henning Gall, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Chronic thromboembolic pulmonary hypertension]Stefan Guth, Heinrike Wilkens, Michael Halank, et al.
Respiration; International Review of Thoracic Diseases|February 12, 2011
Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertensionEkkehard Grünig, Nicola Ehlken, Ardeschir Ghofrani, et al.
Respiration; International Review of Thoracic Diseases|November 21, 2021
Value of Cardiopulmonary Exercise Testing in the Prognosis Assessment of Chronic Obstructive Pulmonary Disease Patients: A Retrospective, Multicentre Cohort StudyRalf Ewert, Anne Obst, Andreas Mühle, et al.
BMC Pulmonary Medicine|December 3, 2011
Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapyLars Knudsen, Alexander Schurawlew, Nils Nickel, et al.
Respiratory Research|October 11, 2013
Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionDominik Harzheim, Hans Klose, Fabiola Peña Pinado, et al.
Pageof 14